These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28940143)

  • 1. Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.
    Barateau L; Liblau R; Peyron C; Dauvilliers Y
    CNS Drugs; 2017 Oct; 31(10):821-834. PubMed ID: 28940143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Narcolepsy.
    Barateau L; Lopez R; Dauvilliers Y
    Curr Treat Options Neurol; 2016 Oct; 18(10):43. PubMed ID: 27549768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narcolepsy during Childhood: An Update.
    Rocca FL; Pizza F; Ricci E; Plazzi G
    Neuropediatrics; 2015 Jun; 46(3):181-98. PubMed ID: 25961600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection, vaccination and narcolepsy type 1: Evidence and potential molecular mechanisms.
    Ayoub I; Freeman SA; Saoudi A; Liblau R
    J Neuroimmunol; 2024 Aug; 393():578383. PubMed ID: 39032452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy.
    Williams RH; Tsunematsu T; Thomas AM; Bogyo K; Yamanaka A; Kilduff TS
    J Neurosci; 2019 Nov; 39(47):9435-9452. PubMed ID: 31628177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in treatment for narcolepsy.
    Barateau L; Dauvilliers Y
    Ther Adv Neurol Disord; 2019; 12():1756286419875622. PubMed ID: 31632459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?
    Buonocore SM; van der Most RG
    Front Immunol; 2022; 13():902840. PubMed ID: 36311717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep, sleep disorders and hypocretin (orexin).
    Mignot E
    Sleep Med; 2004 Jun; 5 Suppl 1():S2-8. PubMed ID: 15301991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurodegenerative, autoimmune and genetic processes of human and animal narcolepsy].
    Dauvilliers Y
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S83-7. PubMed ID: 14646805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells.
    Lecendreux M; Churlaud G; Pitoiset F; Regnault A; Tran TA; Liblau R; Klatzmann D; Rosenzwajg M
    PLoS One; 2017; 12(1):e0169836. PubMed ID: 28107375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The autoimmune basis of narcolepsy.
    Mahlios J; De la Herrán-Arita AK; Mignot E
    Curr Opin Neurobiol; 2013 Oct; 23(5):767-73. PubMed ID: 23725858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of narcolepsy.
    Miyagawa T; Tokunaga K
    Hum Genome Var; 2019; 6():4. PubMed ID: 30652006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive detection of narcolepsy type I phenotypical features and disease progression by continuous home-cage monitoring of activity in two mouse models: the HCRT-KO and DTA model.
    Piilgaard L; Rose L; Justinussen JL; Hviid CG; Lemcke R; Wellendorph P; Kornum BR
    Sleep; 2023 Sep; 46(9):. PubMed ID: 37210587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic and therapeutic update in narcolepsy].
    Santamaria-Cano J
    Rev Neurol; 2012 May; 54 Suppl 3():S25-30. PubMed ID: 22605629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy.
    De la Herrán-Arita AK; Kornum BR; Mahlios J; Jiang W; Lin L; Hou T; Macaubas C; Einen M; Plazzi G; Crowe C; Newell EW; Davis MM; Mellins ED; Mignot E
    Sci Transl Med; 2013 Dec; 5(216):216ra176. PubMed ID: 24353159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudotumor cerebri syndrome in a patient with narcolepsy type 1.
    Rossor T; Lim M; VanDenEshof K; Gringras P
    Eur J Paediatr Neurol; 2018 Jan; 22(1):194-198. PubMed ID: 29195824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunopathogenesis of narcolepsy type 1.
    Liblau RS; Latorre D; Kornum BR; Dauvilliers Y; Mignot EJ
    Nat Rev Immunol; 2024 Jan; 24(1):33-48. PubMed ID: 37400646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapeutic targets for narcolepsy.
    Vringer M; Kornum BR
    Expert Opin Ther Targets; 2021 Jul; 25(7):559-572. PubMed ID: 34402358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.
    Bassetti CLA; Adamantidis A; Burdakov D; Han F; Gay S; Kallweit U; Khatami R; Koning F; Kornum BR; Lammers GJ; Liblau RS; Luppi PH; Mayer G; Pollmächer T; Sakurai T; Sallusto F; Scammell TE; Tafti M; Dauvilliers Y
    Nat Rev Neurol; 2019 Sep; 15(9):519-539. PubMed ID: 31324898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.